Vaxess Technologies
vaxess.comLocations
Boston, MA, USA · North America · Cambridge, MA, USA
industry
Health · Manufacturing · DeepTech
Size
11-50 employees
Stage
Series B
founded in
2012
Vaxess is commercializing a proprietary technology that uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration and a novel sustained release microneedle for improved vaccine delivery. Vaxess strives to not only lower the cost of vaccine distribution, but also increase access to life-saving products for people around the world.
Inaccurate data? Flag it here.Open jobs at Vaxess Technologies